Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
The OncLive Insider app is live!
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Treating Advanced Breast Cancer in Community Settings
EP. 1: Introduction: Chemotherapies for Advanced Breast Cancer
August 7th 2014
EP. 2: Nab-Paclitaxel in Metastatic Breast Cancer
August 7th 2014
EP. 3: Exceptional Responders in Breast Cancer
August 7th 2014
EP. 4: First-Line Treatment of HER2-Positive MBC
August 7th 2014
EP. 5: HER2 Testing Challenges in Metastatic Breast Cancer
August 7th 2014
EP. 6: Upfront T-DM1 in HER2-Positive Breast Cancer
August 7th 2014
EP. 7: Utilizing pCR in Breast Cancer Trials
August 7th 2014
EP. 8: Fitting T-DM1 Into Established Upfront Treatment Paradigms
August 7th 2014
EP. 9: T-DM1 Plus Pertuzumab in the MARIANNE Trial
August 7th 2014
EP. 10: Frontline Treatment of ER-Positive Breast Cancer
August 7th 2014
EP. 11: Second-Line Everolimus in Metastatic Breast Cancer
August 7th 2014
EP. 12: Managing the Toxicity of Everolimus in Breast Cancer
August 7th 2014
EP. 13: Adjuvant Everolimus and CDK4/6 Trials in Breast Cancer
August 7th 2014
EP. 14: TEXT/SOFT Findings in HR-Positive Breast Cancer
August 7th 2014
EP. 15: Utilizing Bisphosphonates in Breast Cancer
August 7th 2014
x